I believe that MS will be the next trial after GvHD, company was talking about it since few years now , before cancer came to the picture.

I believe with cancer study they just postponed MS , but they were very impressed with pre-clinical results , and hopefully clinical trial will happen this year...

It is to bad that company , like many other small biotech , is without enough of money to do all at the same time ...